Orphan drug manufacturing
Thanks to Unither's organizational structure and significant manufacturing resources (from a few hundred grams to several tens of kilograms or litres), the company is regularly asked (and agrees) to perform the routine production of drugs for rare and orphan diseases.
Thanks to its flexibility, responsiveness and 10 years' experience of routine production, Unither readily applies its skills to this very particular type of drug.
Unither Développement Bordeaux's strengths
Le développement pharmaceutique de pointe en établissement GMP, et les systèmes de Drug Delivery brevetés
- cutting-edge pharmaceutical development in a GMP-compliant facility.
- patented drug delivery systems.
- technical expertise and consultancy in pharmaceutical development.
- rapid start-up and short delivery timelines.
- incorporation of an industrial mindset from the formulation step onwards, providing technical efficiency and cost-effectiveness.
- a multicustomer culture and international experience.
